|
5/17/2013 10:02:27 AM
|
Shire To Present Scientific Data Across Range Of Psychiatric Disorders At ASA Annual Meeting
|
|
5/9/2013 12:35:48 PM
|
|
|
5/9/2013 12:01:16 PM
|
Shire Subsidiary Wins Patent Trial Against Watson Concerning LIALDA
|
|
5/2/2013 10:08:36 AM
|
Acceleron And Shire Conclude Collaboration On ACE-031
|
|
5/2/2013 8:32:29 AM
|
|
|
5/2/2013 7:20:11 AM
|
Shire Q1 Total Revenue Down 1% To $1.16 Bln
|
|
5/2/2013 7:19:40 AM
|
Shire Q1 Earnings Per ADS Drop 72% To $0.35
|
|
5/1/2013 3:53:46 PM
|
Shire Says FDA Approves Prescription Medication Vyvanse Capsules
|
|
4/25/2013 10:19:36 AM
|
Shire Settles All Pending Litigation With Actavis And Watson Concerning INTUNIV
|
|
4/25/2013 9:29:06 AM
|
Actavis Reaches Agreement With Shire To Launch Generic Version Of Intuniv In December 2014
|
|
3/25/2013 8:11:32 AM
|
|
|
3/25/2013 8:04:31 AM
|
Shire Plc To Acquire Privately Held Biopharmaceutical Company SARcode Bioscience
|
|
3/12/2013 8:02:42 AM
|
Shire Plc Acquires Premacure AB
|
|
2/28/2013 10:01:32 AM
|
Nomura Downgrades Shire plc (SHP.L) To Neutral From Buy
|
|
2/14/2013 2:31:11 PM
|
|
|
2/14/2013 9:13:26 AM
|
|
|
2/14/2013 8:53:53 AM
|
|
|
2/14/2013 7:32:01 AM
|
|
|
2/14/2013 7:10:36 AM
|
Shire Posts Q4 Earnings/ADS Of 22.2c Vs. 133.2c Last Year
|
|
2/11/2013 3:43:26 AM
|
|